Hospitals segment is expected to drive the growth of the global Atrial Fibrillation Market by End User
 

According to a new market research study of ‘Atrial Fibrillation Market to 2027 - Global Analysis and Forecasts by Treatment Type and End User.’ The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving the market along with those that act as hindrances.

Atrial fibrillation, is the most common type of heart disorder, where the heart beats too fast, too slow, or in an irregular way. The Centers for Disease Control and Prevention (CDC) estimated that between 2.7 million and 6.1 million people are suffering from AFib in the United States. In 2017, around 166,793 death certificates mention AFib and was the main cause death in 26,077 deaths. Every year over 454,000 hospitalizations were due to AFib in the United States and every year about 158,000 deaths are due to atrial fibrillation.

Furthermore, European Society of Cardiology reported that Atrial fibrillation is the most common arrhythmia and accounts for 0.28% to 2.6% of healthcare spending in European countries. It also mentioned that patients suffering from atrial fibrillation have a five times higher risk getting a stroke and 20% to 30% of total strokes in Europe are caused due to atrial fibrillation. As per the study conducted by the European Society of Cardiology in 2016, approximately 7.6 million people aged 65 or more in the EU had atrial fibrillation. The European Society of Cardiology estimated that the number is expected to increase by 89% in 2060 and approximately 14.4 million people will have atrial fibrillation. And the prevalence of 7.8% is expected to reach 9.5% in 2060.

The global atrial fibrillation market, based on end user, was segmented as hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. The hospitals segment held the largest share of the market in 2019. In addition, the segment is also estimated to register the highest CAGR in the market during the forecast period. The hospital segment held the largest share as hospitals are primary point of care for most of the population across the globe and the treatment procedures for atrial fibrillation are easily carried out in the hospitals due to availability of the experienced cardiologists, experts and assisting staffs.
 
Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.

The report segments Global Atrial Fibrillation Market as follows:

Global Atrial Fibrillation Market - By Treatment Type

• Non - pharmacological
  • MAZE Surgery
  • Catheter Ablation
  • Electric Cardioversion
• Pharmacological
  • Anti-arrhythmic Drugs
  • Anti-coagulant Drugs

Global Atrial Fibrillation Market - By End User

• Hospitals
• Ambulatory Surgical Centers,
• Cardiac Catheterization Laboratories

Global Atrial Fibrillation Market - By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • U.K
  • Spain
  • Italy
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East & Africa (MEA)
  • Saudi Arabia
  • U.A.E
  • South Africa
• South & Central America (SCAM)
  • Brazil
  • Argentina

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com